Results 1 to 10 of about 136,717 (175)
Magnitude of atopic dermatitis and associated factors among children in northwest Ethiopia [PDF]
Scientific ReportsAtopic dermatitis is a chronic inflammatory skin disease that typically begins in infancy and extends into adulthood in a small proportion of cases. Around 20% of children and 5% of adults worldwide suffer from atopic dermatitis.
Alemu Bezabih Tegegnie +4 more
doaj +2 more sources
Cutis, 2021 A) Pink scaling plaques and erythematous erosions in the antecubital fossae of a 6-year-old White boy. B) Violaceous, hyperpigmented, nummular plaques on the back and extensor surface of the right arm of a 16-month-old Black girl. C) Atopic dermatitis and follicular prominence/accentuation on the neck of a young Black girl.
Candrice R, Heath, Richard P, Usatine
openaire +6 more sources
Allergy, Asthma & Clinical Immunology, 2011 Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects in skin barrier function, environmental and infectious ...
Wade Watson, Sandeep Kapur
openaire +6 more sources
Allergy, Asthma & Clinical Immunology, 2018 Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects in skin barrier function, environmental and infectious ...
Sandeep Kapur, Wade Watson, Stuart Carr
+8 more sources
New England Journal of Medicine, 2008 Atopic dermatitis (AD) is a chronic and relapsing disease affecting an increasing number of patients. Usually starting in early childhood, AD can be the initial step of the so-called atopic march, i.e. followed by allergic rhinitis and allergic asthma.
BUGGIANI, GIONATA +2 more
openaire +6 more sources
Acta Dermato-Venereologica, 2023 Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes +8 more
doaj +1 more source
Acta Dermato-Venereologica, 2021 Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort
Lieneke F.M. Ariëns +9 more
doaj +1 more source
Oral food challenges in children [PDF]
Korean Journal of Pediatrics, 2011 Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum +9 more
doaj +1 more source
Clinical and Translational Allergy, 2023 Background The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity ...
Roselie Achten +13 more
doaj +1 more source
Acta Dermato-Venereologica, 2023 Although isotretinoin has anti-inflammatory and immunomodulatory properties, it can exacerbate atopic dermatitis. National estimates of the extent to which patients with atopic dermatitis are affected by severe acne and isotretinoin tolerability are ...
Cathrine H. Mohn +4 more
doaj +1 more source